Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Xvivo Perfusion AB

Closing information (x1000 EUR)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 37,319 Less Arrow 25,265 Less Arrow 17,919
Financial expenses 5,005 Less Arrow 1,976 Less Arrow 1,243
Earnings before taxes 2,005 Less Arrow 652 Less Arrow -5,705
EBITDA 4,365 Less Arrow -729
Total assets 155,737 Less Arrow 150,837 Less Arrow 114,601
Current assets 42,011 More Arrow 53,538 Less Arrow 46,150
Current liabilities 12,122 Less Arrow 10,220 Less Arrow 7,198
Equity capital 128,513 Less Arrow 125,693 Less Arrow 100,469
- share capital 68 More Arrow 74 Less Arrow 68
Employees (average) 114 Less Arrow 92 Less Arrow 63

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 82.5% More Arrow 83.3% More Arrow 87.7%
Turnover per employee 327 Less Arrow 275 More Arrow 284
Profit as a percentage of turnover 5.4% Less Arrow 2.6% Less Arrow -31.8%
Return on assets (ROA) 4.5% Less Arrow 1.7% Less Arrow -3.9%
Current ratio 346.6% More Arrow 523.9% More Arrow 641.2%
Return on equity (ROE) 1.6% Less Arrow 0.5% Less Arrow -5.7%
Change turnover 14,100 Less Arrow 7,678 Less Arrow -4,082
Change turnover % 61% Less Arrow 44% Less Arrow -19%
Chg. No. of employees 22 More Arrow 29 Less Arrow 17
Chg. No. of employees % 24% More Arrow 46% Less Arrow 37%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.